209 related articles for article (PubMed ID: 33836067)
1. Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2 Following the Largest Initial Epidemic Wave in the United States: Findings From New York City, 13 May to 21 July 2020.
Pathela P; Crawley A; Weiss D; Maldin B; Cornell J; Purdin J; Schumacher PK; Marovich S; Li J; Daskalakis D;
J Infect Dis; 2021 Jul; 224(2):196-206. PubMed ID: 33836067
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of SARS-CoV-2 Antibodies in First Responders and Public Safety Personnel, New York City, New York, USA, May-July 2020.
Sami S; Akinbami LJ; Petersen LR; Crawley A; Lukacs SL; Weiss D; Henseler RA; Vuong N; Mackey L; Patel A; Grohskopf LA; Morgenthau BM; Daskalakis D; Pathela P
Emerg Infect Dis; 2021 Mar; 27(3):796-804. PubMed ID: 33493106
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of SARS-CoV-2 Antibodies in New York City Adults, June-October 2020: A Population-Based Survey.
Parrott JC; Maleki AN; Vassor VE; Osahan S; Hsin Y; Sanderson M; Fernandez S; Levanon Seligson A; Hughes S; Wu J; DeVito AK; LaVoie SP; Rakeman JL; Gould LH; Alroy KA
J Infect Dis; 2021 Jul; 224(2):188-195. PubMed ID: 34086923
[TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2 antibody seroprevalence in India, August-September, 2020: findings from the second nationwide household serosurvey.
Murhekar MV; Bhatnagar T; Selvaraju S; Saravanakumar V; Thangaraj JWV; Shah N; Kumar MS; Rade K; Sabarinathan R; Asthana S; Balachandar R; Bangar SD; Bansal AK; Bhat J; Chopra V; Das D; Deb AK; Devi KR; Dwivedi GR; Khan SMS; Kumar CPG; Kumar MS; Laxmaiah A; Madhukar M; Mahapatra A; Mohanty SS; Rangaraju C; Turuk A; Baradwaj DK; Chahal AS; Debnath F; Haq I; Kalliath A; Kanungo S; Kshatri JS; Lakshmi GGJN; Mitra A; Nirmala AR; Prasad GV; Qurieshi MA; Sahay S; Sangwan RK; Sekar K; Shukla VK; Singh PK; Singh P; Singh R; Varma DS; Viramgami A; Panda S; Reddy DCS; Bhargava B;
Lancet Glob Health; 2021 Mar; 9(3):e257-e266. PubMed ID: 33515512
[TBL] [Abstract][Full Text] [Related]
5. Seroprevalence of SARS-CoV-2 Infection in Portugal in May-July 2020: Results of the First National Serological Survey (ISNCOVID-19).
Kislaya I; Gonçalves P; Barreto M; Sousa R; Garcia AC; Matos R; Guiomar R; Rodrigues AP;
Acta Med Port; 2021 Feb; 34(2):87-94. PubMed ID: 33641702
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of SARS-CoV-2 antibodies in a large nationwide sample of patients on dialysis in the USA: a cross-sectional study.
Anand S; Montez-Rath M; Han J; Bozeman J; Kerschmann R; Beyer P; Parsonnet J; Chertow GM
Lancet; 2020 Oct; 396(10259):1335-1344. PubMed ID: 32987007
[TBL] [Abstract][Full Text] [Related]
7. Seroprevalence of anti-SARS-CoV-2 antibodies in Iquitos, Peru in July and August, 2020: a population-based study.
Álvarez-Antonio C; Meza-Sánchez G; Calampa C; Casanova W; Carey C; Alava F; Rodríguez-Ferrucci H; Quispe AM
Lancet Glob Health; 2021 Jul; 9(7):e925-e931. PubMed ID: 34022148
[TBL] [Abstract][Full Text] [Related]
8. SARS-CoV-2 seroprevalence among blood donors after the first COVID-19 wave in Canada.
Saeed S; Drews SJ; Pambrun C; Yi QL; Osmond L; O'Brien SF
Transfusion; 2021 Mar; 61(3):862-872. PubMed ID: 33527398
[TBL] [Abstract][Full Text] [Related]
9. Estimated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Based on Blood Donations, July 2020-May 2021.
Jones JM; Stone M; Sulaeman H; Fink RV; Dave H; Levy ME; Di Germanio C; Green V; Notari E; Saa P; Biggerstaff BJ; Strauss D; Kessler D; Vassallo R; Reik R; Rossmann S; Destree M; Nguyen KA; Sayers M; Lough C; Bougie DW; Ritter M; Latoni G; Weales B; Sime S; Gorlin J; Brown NE; Gould CV; Berney K; Benoit TJ; Miller MJ; Freeman D; Kartik D; Fry AM; Azziz-Baumgartner E; Hall AJ; MacNeil A; Gundlapalli AV; Basavaraju SV; Gerber SI; Patton ME; Custer B; Williamson P; Simmons G; Thornburg NJ; Kleinman S; Stramer SL; Opsomer J; Busch MP
JAMA; 2021 Oct; 326(14):1400-1409. PubMed ID: 34473201
[TBL] [Abstract][Full Text] [Related]
10. Repeated cross-sectional sero-monitoring of SARS-CoV-2 in New York City.
Stadlbauer D; Tan J; Jiang K; Hernandez MM; Fabre S; Amanat F; Teo C; Arunkumar GA; McMahon M; Capuano C; Twyman K; Jhang J; Nowak MD; Simon V; Sordillo EM; van Bakel H; Krammer F
Nature; 2021 Feb; 590(7844):146-150. PubMed ID: 33142304
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of antibodies to SARS-CoV-2 in Irish hospital healthcare workers.
Allen N; Riain UN; Conlon N; Ferenczi A; Carrion Martin AI; Domegan L; Walsh C; Doherty L; O'Farrelly C; Higgins E; Kerr C; McGrath J; ; Fleming C; Bergin C
Epidemiol Infect; 2021 Apr; 149():e157. PubMed ID: 33902786
[TBL] [Abstract][Full Text] [Related]
12. Enhanced surveillance of COVID-19 in Scotland: population-based seroprevalence surveillance for SARS-CoV-2 during the first wave of the epidemic.
Dickson E; Palmateer NE; Murray J; Robertson C; Waugh C; Wallace LA; Mathie L; Heatlie K; Mavin S; Gousias P; Von Wissman B; Goldberg DJ; McAuley A
Public Health; 2021 Jan; 190():132-134. PubMed ID: 33453689
[TBL] [Abstract][Full Text] [Related]
13. Cross-sectional study evaluating the seroprevalence of SARS-CoV-2 antibodies among healthcare workers and factors associated with exposure during the first wave of the COVID-19 pandemic in New York.
Bryan A; Tatem K; Diuguid-Gerber J; Cooke C; Romanoff A; Choudhury N; Scanlon M; Kishore P; Sydney E; Masci J; Bakshi P; Pemmasani S; Davis NJ; Maru D
BMJ Open; 2021 Nov; 11(11):e053158. PubMed ID: 34732494
[TBL] [Abstract][Full Text] [Related]
14. Estimated SARS-CoV-2 Seroprevalence in US Patients Receiving Dialysis 1 Year After the Beginning of the COVID-19 Pandemic.
Anand S; Montez-Rath M; Han J; Cadden L; Hunsader P; Kerschmann R; Beyer P; Boyd SD; Garcia P; Dittrich M; Block GA; Parsonnet J; Chertow GM
JAMA Netw Open; 2021 Jul; 4(7):e2116572. PubMed ID: 34251441
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of SARS-CoV-2 antibodies during phased access to vaccination: results from a population-based survey in New York City, September 2020-March 2021.
Parrott JC; Annibale AM; Osahan S; Alroy K; Caton JA; Chernov C; Dumas S; Fowler RC; Hermosi G; Hsin Y; Perlman S; Wu J; Hughes S; Gould LH; Schuster A
Epidemiol Infect; 2022 May; 150():e105. PubMed ID: 35582988
[TBL] [Abstract][Full Text] [Related]
16. Seroprevalence of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection among Veterans Affairs healthcare system employees suggests higher risk of infection when exposed to SARS-CoV-2 outside the work environment.
Dimcheff DE; Schildhouse RJ; Hausman MS; Vincent BM; Markovitz E; Chensue SW; Deng J; McLeod M; Hagan D; Russell J; Bradley SF
Infect Control Hosp Epidemiol; 2021 Apr; 42(4):392-398. PubMed ID: 32962771
[TBL] [Abstract][Full Text] [Related]
17. The role of housing characteristics in racial and ethnic disparities in SARS-CoV-2 antibody seropositivity among New York City adults: A population representative study.
Gouse I; Walters S; Miller-Archie S; Singh T; Lim S
Prev Med; 2022 Nov; 164():107287. PubMed ID: 36208819
[TBL] [Abstract][Full Text] [Related]
18. Seroprevalence of SARS-CoV-2, Symptom Profiles and Sero-Neutralization in a Suburban Area, France.
Gégout Petit A; Jeulin H; Legrand K; Jay N; Bochnakian A; Vallois P; Schvoerer E; Guillemin F
Viruses; 2021 Jun; 13(6):. PubMed ID: 34200070
[TBL] [Abstract][Full Text] [Related]
19. Seroprevalence of SARS-CoV-2 in Guilan Province, Iran, April 2020.
Shakiba M; Nazemipour M; Salari A; Mehrabian F; Nazari SSH; Rezvani SM; Ghasempour Z; Heidarzadeh A; Mansournia MA
Emerg Infect Dis; 2021 Feb; 27(2):636-638. PubMed ID: 33349310
[TBL] [Abstract][Full Text] [Related]
20. SARS-CoV-2 Seroprevalence Among Healthcare Workers by Job Function and Work Location in a New York Inner-City Hospital.
Purswani MU; Bucciarelli J; Tiburcio J; Yagudayev SM; Connell GH; Omidiran AA; Hannaway L; Zeana C; Healy M; Yu G; Reich D
J Hosp Med; 2021 May; 16(5):282-289. PubMed ID: 33929948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
